China Sky One Medical, Inc. Schedules Conference Call to Discuss First Quarter 2009...

China Sky One Medical, Inc. Schedules Conference Call to Discuss First Quarter
2009 Results

HARBIN, China, May 11 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical,
Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading
fully integrated pharmaceutical company producing over-the-counter drugs in
the People's Republic of China ("PRC"), today announced that it will conduct a
conference call at 10:00 a.m. Eastern Daylight Time (EDT) on Friday, May 15,
2009, to discuss its first quarter of fiscal year 2009 financial results.
Joining Mr. Yan-qing Liu, Chairman and CEO of China Sky One Medical, Inc.,
will be Stanley Hao, Chief Financial Officer. The Company plans to issue an
earnings announcement prior to the call.
To participate in this live conference call, please dial the following
number five to ten minutes prior to the scheduled conference call time: (888)
419-5570. International callers should call (617) 896-9871. The Conference
Passcode is 455 090 46. If you are unable to participate in the call at that
time, replay of the conference call will be available from Friday, May 15,
2009 at 12:00 p.m. Eastern Daylight Time until Friday, May 29, 2009. To access
the replay, call (888) 286-8010. International callers should call (617)
801-6888. The Conference Replay Passcode is 464 826 92.
About China Sky One Medical, Inc.
China Sky One Medical, Inc., a Nevada corporation, is a holding company.
The Company engages in the manufacturing, marketing and distribution of
pharmaceutical, medicinal and diagnostic products. Through its wholly-owned
subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company
("TDR"), Harbin First Bio- Engineering Company Limited ("First"), Heilongjiang
Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin Chuang
Pharmaceutical Company ("Jin Chuang") the Company manufactures and distributes
over-the-counter pharmaceutical products, which make up its major revenue
source. For more information, visit http://www.skyonemedical.com .
Safe Harbor Statement
Certain of the statements made in the press release constitute
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. These statements can be identified by the use
of forward-looking terminology such as "believe," "expect," "may," "will,"
"should," "project," "plan," "seek," "intend," or "anticipate" or the negative
thereof or comparable terminology. Such statements typically involve risks and
uncertainties and may include financial projections or information regarding
our future plans, objectives or performance. Actual results could differ
materially from the expectations reflected in such forward-looking statements
as a result of a variety of factors, including the risks associated with the
effect of changing economic conditions in The People's Republic of China,
variations in cash flow, reliance on collaborative retail partners and on new
product development, variations in new product development, risks associated
with rapid technological change, and the potential of introduced or undetected
flaws and defects in products, and other risk factors detailed in reports
filed with the Securities and Exchange Commission from time to time.
For more information, please contact:

Company Contact:
China Sky One Medical, Inc.
Mr. Stanley Hao, CFO
Tel: +86-451-5399-4069
Email: china_sky_one@yahoo.cn

Investor Relations Contact:
CCG Investor Relations
Mr. Crocker Coulson, President
Tel: +1-646-213-1915
Email: crocker.coulson@ccgir.com
Website: http://www.ccgirasia.com

SOURCE China Sky One Medical, Inc.

Company Contact: Mr. Stanley Hao, CFO of China Sky One Medical, Inc.,
+86-451-5399-4069, or china_sky_one@yahoo.cn; or Investor Relations Contact:
Mr. Crocker Coulson, President, +1-646-213-1915, or crocker.coulson@ccgir.com